Introduction
In vitro cytotoxicity is largely influenced by test article concentration and the exposure period with cells. Depending upon these parameters and the mechanism of action by which cells ultimately die, cells may lose viability early in the exposure (<2 hours) by primary necrosis or at any point thereafter, typically by apoptotic mechanisms. This diversity of kinetic response can greatly complicate conventional cytotoxicity endpoint assay determinations because most assay reagents are formulated to measure enzymatic biomarkers that are susceptible to time-dependent decay
(1)
. Therefore, conventional “add-mix-measure” cytotoxicity assays provide the most value when they are employed in parallel time-point studies
(2)
. Cognizant of these kinetic cytotoxicity complications, we sought to develop an assay system to address this challenge by measuring cytotoxicity in real time.
Identification of a Suitable Cytotoxicity Probe
Membrane integrity, or lack thereof, has been an operational definition for viability and cytotoxicity for decades
(3)
. Therefore the ability to differentially exclude dye from viable cells served as a starting point for the evaluation of over one hundred novel asymmetric cyanine dyes. These dyes, designed and synthesized by Promega Biosciences, demonstrated affinity for binding genomic DNA, which led to an increase in fluorescence in the presence of dead cells (Figure 1). The dyes were screened using artificially blended ratios of viable and non-viable cells and proved to reliably measure incremental differences in viability across the cytotoxicity spectrum (Figure 2, Panels A and B).
Flexibility in CellTox™ Green Dye Delivery
Lead candidates that demonstrated exceptional cell impermeability and quantum yield (a measure of “brightness”) were evaluated further for biological inertness by long-term (72-hour) exposures with cells followed by orthogonal viability measures. These studies, performed with both primary and transformed cell lines, suggest that a particular dye, the CellTox™ Green Dye, can be delivered either at dosing or at the exposure endpoint with satisfactory signal windows and robustness. Furthermore, for endpoint application, the dye can be delivered in the provided buffer (or medium) in an equal volume or at more concentrated, lower volumes. This range of protocol options (Figure 3) allows significant downstream, same-well multiplexing opportunities for more informative data per well
(4)
.

Figure 3. Schematic diagram of methods for delivering the CellTox™ Green Dye. 
Kinetic Measurements of Cytotoxicity
Next, we sought to determine the utility of the profluorescent probe in kinetic measures of cytotoxicity. In the first experiment, we treated K562 cells at a density of 10,000 cells per well in a black 96-well plate in the presence of CellTox™ Green Dye with increasing concentrations of the potent proteasome inhibitor, bortezomib. Fluorescence was measured with an excitation source at 485nm and emission at 520nm using a BMG PolarStar™ reader at 4, 24, 48 and 72 hours post-compound addition. The plate was returned to a 37°C humidified incubator between measurements. The resulting data were plotted as raw fluorescence vs. dosage and demonstrate the cytotoxicity relationship between dosage and exposure time (Figure 4). Most notably, loss of membrane integrity is evident by 24 hours and persistent and accumulative out to 72 hours after compound addition. This indicates that genomic DNA, although actively degraded by inherent nuclease activity, is sufficiently stable to act as a reliable biomarker for cytotoxicity. These data also demonstrate that time course data can be collected from the same assay plate instead of requiring parallel plates, thereby reducing unnecessary duplication of effort required for endpoint measures. Furthermore, same-well time-point analysis allows application of multiplexed, spectrally distinct assay chemistry such as Caspase-Glo® 3/7 Reagent at the first indication of cytotoxicity (Figure 5). This concurrent analysis allows researchers to establish mechanism-of-action for cytotoxicity.
In the second experiment, we chose to examine the respective kinetics of cytotoxicity provoked by two unrelated agents. Frozen instant HepG2 cells (provided by Cell Culture Service) at a density of 10,000 cells/well were treated with tenfold serial dilutions of either nocodazole or terfenadine (Figure 6). The Tecan HP D300 Digital Dispenser was used for compound addition. CellTox™ Green Dye was introduced into the cultures at cell plating. Fluorescence associated with the progression of cytotoxicity was monitored, and data were collected in real time in an environmentally controlled Tecan Infinite® 200 PRO reader with Gas Control Module (GCM™) using bottom-read fluorescence, shaking the plate before each read. The real-time data reveal striking discordance in the kinetics and potency of the cytotoxic events both within individual concentration of the same drug and between two compounds. Ultimately, these types of cytotoxicity profiles are essential for understanding mechanism of action and addressing possible pharmokinetic concerns such as biotransformation of the compound during the exposure period.
Summary
Conventional “add-mix-measure” endpoint cytotoxicity assays continue to be an integral aspect of biological experimentation because they are easy to use and provide exceptional value. However, they can be more costly to employ in terms of time and effort because they require parallel time-point studies to fully characterize a cytotoxic event. The CellTox™ Green Assay eliminates this unnecessary duplication of effort by allowing real-time cytotoxicity measurements, whether employed at specified time points using the same assay plate or by collecting cytotoxicity data in real time with specialized fluorometers.
Acknowledgments
The authors would like to thank Tecan for providing the Infinite Pro with GCM™ and Cell Culture Service for the Frozen Instant HepG2 cells used in this study.